相关实验视频

Updated: May 20, 2025

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

SARS-CoV-2 S1蛋白诱导IgG介导的血小板激活,并被1.8-cineole阻止

Julie Petry¹, Maria Shoykhet¹, Tobias Weiser¹

¹Technical University of Munich, School of Medicine and Health, Department of Otorhinolaryngology, Head and Neck Surgery, TUM University Hospital, Germany.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|April 30, 2025

概括

COVID-19通过SARS-CoV-2 S1尖端蛋白和IgG抗体触发了血小板过活化,导致血液凝块. 化合物1.8-cineole有效地抑制了这种血小板激活,为COVID-19并发症提供了潜在的治疗方法.

科学领域:

免疫学免疫学免疫学
血液学血液学血液学
药理学药理学是指药理学的学科.

背景情况:

COVID-19 与血栓栓塞事件的增加有关.
血小板过活化和炎症是严重的COVID-19的关键特征.
血小板在COVID-19病变发生过程中的确切作用需要进一步阐明.

研究的目的:

为了研究SARS-CoV-2 S1尖端蛋白对血小板激活的机制.
评估1.8-cineole在缓解S1-诱导的血小板激活和血栓炎症方面的治疗潜力.

主要方法:

使用S1合珠来诱导血小板激活和聚合在血中.
评估了血小板激活,聚合和血小板-白细胞聚合物 (PLA) 的形成.
研究了1.8-cineole对S1-诱导的血小板反应的影响.

主要成果:

S1诱导的血小板激活和聚合依赖于S1特定的IgG抗体.
通过FcγRIIa交联启动了血小板激活和PLA形成的免疫复合体形成.
1.8-cineole显著抑制了S1-珠诱导的血小板活性和PLA形成.

结论:

通过FcγRIIa的抗体介导的血小板激活有助于COVID-19中的原血栓状态.
1.8-烯醇显示出作为治疗COVID-19相关血栓炎症并发症的治疗剂的潜力.
针对血小板激活提供了一个有希望的策略来管理COVID-19的严重程度和PASC.

关键词:

1.8-cineoleole是什么意思 1.8-cineoleole是什么意思 1.8-cineole是什么意思 1.8-烯醇 (PubChem CID: 2758) 的使用情况.1976年CNL-1976年 CNL-1976 年 CNL-1976 年在 COVID-19 疫情中,免疫球蛋白G是一种免疫球蛋白.免疫血栓形成的疾病.血小板聚合是血小板的聚合.S1 尖端蛋白质的蛋白质这就是SARS-CoV-2病毒.

更多相关视频

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

Engineering Antiviral Agents via Surface Plasmon Resonance

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...